Bioverativ
Bioverativ is a global biotechnology company developing therapies for hemophilia and other rare blood disorders, including sickle cell disease and beta-thalassemia.
Overview
Bioverativ is a global biotechnology company developing therapies for hemophilia and other rare blood disorders, including sickle cell disease and beta-thalassemia.
- Websites:
- Business model: B2B
- Social accounts: linkedin
Industries
Bioverativ is active in the following industries: